Powered by
BioSig Technologies Announces EU Institutional Investor Roadshow

Minneapolis, MN, May 02, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP(TM) System, a proprietary platform designed to address an unmet technology need for the $4 billion electrophysiology (EP) marketplace, is pleased to announce an institutional investor roadshow in the major EU financial centers May 2-5. The roadshow features Kenneth L. Londoner, Chairman of BioSig as the Presenting Speaker and is hosted by Mon

Sign up for unrestricted access to 200+ subscription services.
Already have an account? Click here to login.

RelSci News & Alerts gets you:

  • 5 free articles a month from top subscription outlets like the Financial Times, New York Times, and Washington Post
  • Competitive business intelligence through daily data updates
  • Custom feeds on target high-value individuals, companies, industries, and topics delivered straight to your inbox